title: Lessons learned from a clinical trial.
authors.affiliation: University of Alberta, Edmonton, Alberta, Canada. paul.armstrong@ualberta.ca
authors.forename: Paul W
authors.initials: PW
authors.lastname: Armstrong
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: Kerry L
authors.initials: KL
authors.lastname: Lee
authors.forename: R John
authors.initials: RJ
authors.lastname: Simes
authors.forename: Frans
authors.initials: F
authors.lastname: Van de Werf
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D035843:Biomedical Research / Q000191:economics / Q000941:ethics / Q000592:standards; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000191:economics / Q000627:therapeutic use; D006805:Human Experimentation / Q000941:ethics / Q000592:standards; D006801:Humans; D033183:Interdisciplinary Communication; D015337:Multicenter Studies as Topic / Q000941:ethics / Q000592:standards; D010091:Oximes / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011367:Professional Staff Committees; D011787:Quality of Health Care / Q000592:standards; D016032:Randomized Controlled Trials as Topic / Q000191:economics / Q000941:ethics / Q000592:standards*; D055502:Secondary Prevention
chemical_list: D015507:Drugs, Investigational; D010091:Oximes; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D001241:Aspirin; C100917:sibrafiban